iSpecimen Inc. Increase (Decrease) in Accounts Payable
iSpecimen Inc. (ISPC) reported Increase (Decrease) in Accounts Payable of -$429.13 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-14
- iSpecimen Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$35.44K, a 106.70% decline year-over-year.
- iSpecimen Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$393.69K.
- iSpecimen Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $666.58K, a 368.67% increase year-over-year.
- iSpecimen Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $456.02K.
- iSpecimen Inc. increase (decrease) in accounts payable for fiscal 2025 was $1.24M, a 355.69% increase from fiscal 2024.
- iSpecimen Inc. increase (decrease) in accounts payable for fiscal 2024 was $272.12K, a 81.44% decline from fiscal 2023.
- iSpecimen Inc. increase (decrease) in accounts payable for fiscal 2023 was $1.47M, a 9.84% decline from fiscal 2022.
- iSpecimen Inc. increase (decrease) in accounts payable for fiscal 2022 was $1.63M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$35.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$429.13K 10-Q · filed 2026-08-14 | $237.45K derived: sum of 3 quarters · filed 2026-08-14 | $693.47K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$393.69K 10-Q · filed 2026-05-18 | $272.89K derived: sum of 2 quarters · filed 2026-05-18 | $728.91K derived: sum of 3 quarters · filed 2026-05-18 | $1.26M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $666.58K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $1.12M derived: sum of 2 quarters · filed 2026-04-01 | $1.65M derived: sum of 3 quarters · filed 2026-08-14 | $1.24M 10-K · filed 2026-04-01 |
| 2025-09-30 | $456.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $984.89K derived: sum of 2 quarters · filed 2026-08-14 | $573.47K 10-Q · filed 2025-11-17 | $715.69K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $528.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $117.45K 10-Q · filed 2026-08-14 | $259.68K derived: sum of 3 quarters · filed 2026-08-14 | $109.64K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$411.43K 10-Q · filed 2026-05-18 | -$269.20K derived: sum of 2 quarters · filed 2026-05-18 | -$419.24K derived: sum of 3 quarters · filed 2026-05-18 | $225.66K derived: sum of 4 quarters · filed 2026-05-18 |
| 2024-12-31 | $142.23K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$7.81K derived: sum of 2 quarters · filed 2026-04-01 | $637.09K derived: sum of 3 quarters · filed 2026-04-01 | $272.12K 10-K · filed 2026-04-01 |
| 2024-09-30 | -$150.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $494.86K derived: sum of 2 quarters · filed 2025-11-17 | $129.89K 10-Q · filed 2025-11-17 | $1.78M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $644.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $279.93K 10-Q · filed 2025-08-14 | $1.93M derived: sum of 3 quarters · filed 2025-08-14 | $2.43M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$364.96K 10-Q · filed 2025-05-19 | $1.28M derived: sum of 2 quarters · filed 2025-05-19 | $1.78M derived: sum of 3 quarters · filed 2025-05-19 | $859.24K derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | $2.15M derived: sum of 2 quarters · filed 2025-04-14 | $1.22M derived: sum of 3 quarters · filed 2025-04-14 | $1.47M 10-K · filed 2025-04-14 |
| 2023-09-30 | $500.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$421.07K derived: sum of 2 quarters · filed 2024-11-07 | -$178.90K 10-Q · filed 2024-11-07 | $1.31M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$921.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$679.14K 10-Q · filed 2024-08-06 | $812.18K derived: sum of 3 quarters · filed 2024-08-06 | $1.35M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $242.17K 10-Q · filed 2024-05-07 | $1.73M derived: sum of 2 quarters · filed 2024-05-07 | $2.27M derived: sum of 3 quarters · filed 2024-05-07 | $2.42M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $2.03M derived: sum of 2 quarters · filed 2024-03-13 | $2.18M derived: sum of 3 quarters · filed 2024-03-13 | $1.63M 10-K · filed 2024-03-13 |
| 2022-09-30 | $534.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $686.24K derived: sum of 2 quarters · filed 2023-11-02 | $135.06K 10-Q · filed 2023-11-02 | $616.31K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $151.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$399.65K 10-Q · filed 2023-08-02 | $81.60K derived: sum of 3 quarters · filed 2023-08-02 | -$2.80M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | -$551.18K 10-Q · filed 2023-05-04 | -$69.93K derived: sum of 2 quarters · filed 2023-05-04 | -$2.95M derived: sum of 3 quarters · filed 2023-05-04 | -$1.81M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $481.25K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | -$2.40M derived: sum of 2 quarters · filed 2023-03-30 | -$1.26M derived: sum of 3 quarters · filed 2023-03-30 | -$959.75K 10-K/A · filed 2023-03-30 |
| 2021-09-30 | -$2.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$1.74M derived: sum of 2 quarters · filed 2022-11-08 | -$1.44M 10-Q · filed 2022-11-08 | -$860.63K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.44M 10-Q · filed 2022-08-04 | $2.02M derived: sum of 3 quarters · filed 2022-08-04 | $2.35M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $299.13K 10-Q · filed 2022-05-10 | $879.50K derived: sum of 2 quarters · filed 2022-05-10 | $1.21M derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $580.38K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $908.44K derived: sum of 2 quarters · filed 2022-03-22 | $1.05M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $328.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $474.26K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $146.20K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |